GP1BA
Platelet glycoprotein Ib alpha chain
Also known as: CD42b, GP1B, GP1BA_HUMAN, GPIbalpha
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P07359
- Gene
- GP1BA
- Ensembl
- ENSG00000185245
- Chromosome
- 17
- Canonical length
- 652 aa
- Protein class
- CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins
OverviewNCBI Gene
Glycoprotein Ib (GP Ib) is a platelet surface membrane glycoprotein composed of a heterodimer, an alpha chain and a beta chain, that is linked by disulfide bonds. The Gp Ib functions as a receptor for von Willebrand factor (VWF). The complete receptor complex includes noncovalent association of the alpha and beta subunits with platelet glycoprotein IX and platelet glycoprotein V. The binding of the GP Ib-IX-V complex to VWF facilitates initial platelet adhesion to vascular subendothelium after vascular injury, and also initiates signaling events within the platelet that lead to enhanced platelet activation, thrombosis, and hemostasis. This gene encodes the alpha subunit. Mutations in this gene result in Bernard-Soulier syndromes and platelet-type von Willebrand disease. The coding region of this gene is known to contain a polymophic variable number tandem repeat (VNTR) domain that is associated with susceptibility to nonarteritic anterior ischemic optic neuropathy. [provided by RefSeq, Oct 2013]
Canonical amino-acid sequenceUniProt
652 residues, UniProt reviewed canonical sequence.
>P07359|GP1BA
1 MPLLLLLLLL PSPLHPHPIC EVSKVASHLE VNCDKRNLTA LPPDLPKDTT ILHLSENLLY
61 TFSLATLMPY TRLTQLNLDR CELTKLQVDG TLPVLGTLDL SHNQLQSLPL LGQTLPALTV
121 LDVSFNRLTS LPLGALRGLG ELQELYLKGN ELKTLPPGLL TPTPKLEKLS LANNNLTELP
181 AGLLNGLENL DTLLLQENSL YTIPKGFFGS HLLPFAFLHG NPWLCNCEIL YFRRWLQDNA
241 ENVYVWKQGV DVKAMTSNVA SVQCDNSDKF PVYKYPGKGC PTLGDEGDTD LYDYYPEEDT
301 EGDKVRATRT VVKFPTKAHT TPWGLFYSWS TASLDSQMPS SLHPTQESTK EQTTFPPRWT
361 PNFTLHMESI TFSKTPKSTT EPTPSPTTSE PVPEPAPNMT TLEPTPSPTT PEPTSEPAPS
421 PTTPEPTSEP APSPTTPEPT SEPAPSPTTP EPTPIPTIAT SPTILVSATS LITPKSTFLT
481 TTKPVSLLES TKKTIPELDQ PPKLRGVLQG HLESSRNDPF LHPDFCCLLP LGFYVLGLFW
541 LLFASVVLIL LLSWVGHVKP QALDSGQGAA LTTATQTTHL ELQRGRQVTV PRAWLLFLRG
601 SLPTFRSSLF LWVRPNGRVG PLVAGRRPSA LSQGRGQDLL STVSIRYSGH SLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GP1BA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 14 nTPM
- tonsil: 7.2 nTPM
- bone marrow: 4.6 nTPM
- appendix: 3.6 nTPM
- spleen: 3.4 nTPM
- skeletal muscle: 2.5 nTPM
Single-cell type
- platelets: 321 nCPM
- megakaryocytes: 185 nCPM
- megakaryocyte progenitors: 80 nCPM
- thymic myoid cells: 6.8 nCPM
- hepatic stellate cells: 6.5 nCPM
- epicardial cells: 4.5 nCPM
Immune cell
- basophil: 7 nTPM
- total PBMC: 2.1 nTPM
- neutrophil: 0.5 nTPM
- intermediate monocyte: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
- myeloid DC: 0.1 nTPM
Brain region
- cerebellum: 8.3 nTPM
- cerebral cortex: 4.6 nTPM
- basal ganglia: 4.5 nTPM
- thalamus: 3.7 nTPM
- amygdala: 3.6 nTPM
- hippocampal formation: 3.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GP1BA.
Disease | AllUniProt
Conditions GP1BA is implicated in, by any mechanism.
- Non-arteritic anterior ischemic optic neuropathy (NAION) MIM:258660
- Bernard-Soulier syndrome (BSS) MIM:231200
- Bernard-Soulier syndrome A2, autosomal dominant (BSSA2) MIM:153670
- von Willebrand disease, platelet-type (VWDP) MIM:177820
Disease | GeneticClinVar
94 pathogenic / likely-pathogenic of 341 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Bernard Soulier syndrome
- Bernard-Soulier syndrome, type A2, autosomal dominant
- Pseudo von Willebrand disease
- Nonarteritic anterior ischemic optic neuropathy, susceptibility to
- Thrombocytopenia
Disease | AutoantibodyPubMed
Conditions in which antibodies against GP1BA are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for GP1BA from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
20 publications
- Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice.
2000 · Blood · RCR 4.1 · 214 citations - Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.
2006 · Arthritis Rheum · RCR 3.6 · 137 citations - Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodies.
2012 · Am J Hematol · RCR 2.6 · 89 citations - Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia.
2018 · Proc Natl Acad Sci U S A · RCR 2.6 · 60 citations - Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies.
2006 · Blood · RCR 2.5 · 107 citations
Show 15 more
- Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2' and glycoprotein I bα.
2016 · Front Med · RCR 1.9 · 46 citations - The role of protein kinase C and the glycoprotein Ibα cytoplasmic tail in anti-glycoprotein Ibα antibody-induced platelet apoptosis and thrombocytopenia.
2024 · Thromb Res · RCR 1.6 · 7 citations - Platelet desialylation and TFH cells-the novel pathway of immune thrombocytopenia.
2021 · Exp Hematol Oncol · RCR 1.2 · 17 citations - Glycoprotein Ibα clustering induces macrophage-mediated platelet clearance in the liver.
2015 · Thromb Haemost · RCR 1.1 · 35 citations - Quinine-dependent antibodies bind a restricted set of epitopes on the glycoprotein Ib-IX complex: characterization of the epitopes.
1998 · Blood · RCR 0.9 · 36 citations - Anti-glycoprotein Ibα autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patients.
2020 · Haematologica · RCR 0.8 · 15 citations - The glycoprotein Ib-IX complex-specific monoclonal antibody SZ1 binds to a conformation-sensitive epitope on glycoprotein IX: implications for the target antigen of quinine/quinidine-dependent autoantibodies.
1995 · Blood · RCR 0.7 · 28 citations - Detection of anti-GPIbα autoantibodies in a case of immune thrombocytopenia following COVID-19 vaccination.
2022 · Thromb Res · RCR 0.7 · 8 citations - The Levels of T Lymphocyte Subsets in Immune Thrombocytopenia Associated with Anti-GPIIb/IIIa- and/or Anti-GPIbα-Mediated Responses Are Differentially Sensitive to Dexamethasone.
2018 · Acta Haematol · RCR 0.5 · 10 citations - The Fc gammaRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patients.
2005 · Thromb Haemost · RCR 0.2 · 8 citations - Platelets are not critical effector cells for the time course of murine passive crescentic glomerulonephritis.
2013 · Platelets · RCR 0.2 · 4 citations - [Study on the relationship of platelet specific-autoantibodies with therapeutic outcomes by dexamethasone in immune thrombocytopenia purpura].
2015 · Zhonghua Xue Ye Xue Za Zhi · RCR 0.1 · 2 citations - [Relationship between platelet specific antibodies and the onset, clinical manifestation, treatment and prognosis of ITP].
2014 · Zhongguo Shi Yan Xue Ye Xue Za Zhi - [Influence of Anticoagulants on Detection of ITP Platelet-Specific Autoantibodies and Relationship of Autoantibody Types with Glucocorticoid Efficacy].
2015 · Zhongguo Shi Yan Xue Ye Xue Za Zhi - CD19 chimeric antigen receptor-T cell therapy in murine immune thrombocytopenia.
2025 · Br J Haematol · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.3
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood coagulation
- blood coagulation, intrinsic pathway
- cell adhesion
- cell morphogenesis
- cell surface receptor signaling pathway
- fibrinolysis
- megakaryocyte development
- platelet activation
- positive regulation of platelet activation
- regulation of blood coagulation
- release of sequestered calcium ion into cytosol
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GP1BA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GP1BA as an antibody target. Whether an autoantibody or antibody against GP1BA could matter depends on whether native GP1BA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GP1BA is annotated at the cell surface, where native GP1BA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GP1BA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...